Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression
NCT: NCT03653858 · COMPLETED
Publicidade
ID NCTNCT03653858
EstadoCOMPLETED
Data de início2018-09-03
Conclusão2026-01-07
Resumo breve
The primary objective of this multicenter, randomized, sham-controlled, double blind (patient and observer blinded) clinical trial is to assess the antidepressant effect of Deep Brain Stimulation (DBS) in patients with treatment resistant major depression using the Boston Scientific implantable Vercise™ GEVIA™ DBS system compared to sham.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.